NTRA Q1 2019 Earnings — Natera, Inc. Revenue & Financial Results | Market Cap Arena

NTRANatera, Inc.

$28B

Q1 2019 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$67M+7.2% YoY

Gross Profit

$24M35.2% margin

Operating Income

-$32M-47.5% margin

Net Income

-$34M-51.0% margin

EPS (Diluted)

$-0.54

QoQ Revenue Growth

-0.2%

Cash Flow

Operating Cash Flow

-$32M

Free Cash Flow

-$33M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$261M

Total Liabilities

$256M

Stockholders' Equity

$5M

Cash & Equivalents

$34M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$67M	$62M	+7.2%
Gross Profit	$24M	$22M	+8.2%
Operating Income	-$32M	-$31M	-4.0%
Net Income	-$34M	-$33M	-3.7%

Revenue Segments

Product

$63M47%

Panorama Nipt

$37M28%

Hcs

$23M17%

Licensing And Other

$3M3%

Other Genetic Tests

$3M3%

Other Licensing And Other

$2M1%

Constellation

$1M1%

Qiagen

$148,0000%

Geographic Segments

U

$60M90%

E M E A

$4M6%

Other Geographic Areas

$2M3%

Americas Excluding Us

$818,0001%